{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:08:54Z","timestamp":1787735334973,"version":"build-2784847793"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.taap.2021.115859","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T20:46:36Z","timestamp":1641242796000},"page":"115859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Roflupram attenuates \u03b1-synuclein-induced cytotoxicity and promotes the mitochondrial translocation of Parkin in SH-SY5Y cells overexpressing A53T mutant \u03b1-synuclein"],"prefix":"10.1016","volume":"436","author":[{"given":"Jiahong","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengfan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqing","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2021.115859_bb0005","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1021\/acs.jcim.1c00034","article-title":"Hydration thermodynamics of familial Parkinson\u2019s disease-linked mutants of alpha-synuclein","volume":"61","author":"Aggarwal","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.taap.2021.115859_bb0010","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1126\/science.aar6606","article-title":"Parkin function in Parkinson\u2019s disease","volume":"360","author":"Arkinson","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.taap.2021.115859_bb0015","doi-asserted-by":"crossref","first-page":"12842","DOI":"10.1074\/jbc.M608243200","article-title":"Phosphorylation of Parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation","volume":"282","author":"Avraham","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2021.115859_bb0020","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.febslet.2010.03.012","article-title":"Alpha-synuclein induced membrane depolarization and loss of phosphorylation capacity of isolated rat brain mitochondria: implications in Parkinson\u2019s disease","volume":"584","author":"Banerjee","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.taap.2021.115859_bb0025","doi-asserted-by":"crossref","first-page":"22650","DOI":"10.1074\/jbc.M113.476283","article-title":"Pannexin 1 channels link chemoattractant receptor signaling to local excitation and global inhibition responses at the front and back of polarized neutrophils","volume":"288","author":"Bao","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2021.115859_bb0030","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1021\/acschemneuro.0c00196","article-title":"Alpha-synuclein regulates Iron homeostasis via preventing Parkin-mediated DMT1 ubiquitylation in Parkinson\u2019s disease models","volume":"11","author":"Bi","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.taap.2021.115859_bb0035","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1124\/mol.105.019539","article-title":"Corticotropin-releasing hormone induces vascular endothelial growth factor release from human mast cells via the cAMP\/protein kinase A\/p38 mitogen-activated protein kinase pathway","volume":"69","author":"Cao","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2021.115859_bb0040","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41419-018-0722-7","article-title":"Phosphorylation of Parkin at serine 131 by p38 MAPK promotes mitochondrial dysfunction and neuronal death in mutant A53T alpha-synuclein model of Parkinson\u2019s disease","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.taap.2021.115859_bb0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neulet.2010.09.061","article-title":"Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo","volume":"486","author":"Chinta","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.taap.2021.115859_bb0050","doi-asserted-by":"crossref","first-page":"6593","DOI":"10.1111\/febs.15674","article-title":"Molecular events underlying the cell-to-cell transmission of alpha-synuclein","volume":"288","author":"Choi","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.taap.2021.115859_bb0055","doi-asserted-by":"crossref","first-page":"eaba1193","DOI":"10.1126\/sciadv.aba1193","article-title":"Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological alpha-synuclein","volume":"6","author":"Chung","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.taap.2021.115859_bb0060","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.taap.2021.115859_bb0065","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1073\/pnas.97.2.571","article-title":"Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson\u2019s disease: implications for pathogenesis and therapy","volume":"97","author":"Conway","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2021.115859_bb0070","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.taap.2021.115859_bb0075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3233\/JPD-191790","article-title":"Protein quality control pathways at the crossroad of synucleinopathies","volume":"10","author":"De Mattos","year":"2020","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.taap.2021.115859_bb0080","doi-asserted-by":"crossref","first-page":"9034","DOI":"10.1074\/jbc.M116.767053","article-title":"A sensitive assay reveals structural requirements for alpha-synuclein fibril growth","volume":"292","author":"Dhavale","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2021.115859_bb0085","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00401-021-02266-7","article-title":"Lipids, lysosomes and mitochondria: insights into Lewy body formation from rare monogenic disorders","volume":"141","author":"Erskine","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.taap.2021.115859_bb0090","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/mds.28396","article-title":"The role of cholesterol in alpha-synuclein and Lewy body pathology in GBA1 Parkinson\u2019s disease","volume":"36","author":"Garcia-Sanz","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.taap.2021.115859_bb0095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13024-020-00367-7","article-title":"PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson\u2019s disease","volume":"15","author":"Ge","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.taap.2021.115859_bb0100","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00018-005-5433-4","article-title":"Multiple cAMP-induced signaling cascades regulate prolactin expression in T cells","volume":"63","author":"Gerlo","year":"2006","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"10.1016\/j.taap.2021.115859_bb0105","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1189\/jlb.2VMA1216-517R","article-title":"Early tyrosine phosphorylation events following adenosine A2A receptor in human neutrophils: identification of regulated pathways","volume":"102","author":"Giambelluca","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.taap.2021.115859_bb0110","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.bcp.2019.08.002","article-title":"Parkin is transcriptionally regulated by the aryl hydrocarbon receptor: impact on alpha-synuclein protein levels","volume":"168","author":"Gonzalez-Barbosa","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2021.115859_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101795","article-title":"Inhibition of copper transporter 1 prevents alpha-synuclein pathology and alleviates nigrostriatal degeneration in AAV-based mouse model of Parkinson\u2019s disease","volume":"38","author":"Gou","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.taap.2021.115859_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2021.129894","article-title":"A mechanistic review of Parkin activation","volume":"1865","author":"Gundogdu","year":"2021","journal-title":"Biochim. Biophys. Acta, Gen. Subj."},{"key":"10.1016\/j.taap.2021.115859_bb0125","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuropharm.2017.01.004","article-title":"FFPM, a PDE4 inhibitor, reverses learning and memory deficits in APP\/PS1 transgenic mice via cAMP\/PKA\/CREB signaling and anti-inflammatory effects","volume":"116","author":"Guo","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.taap.2021.115859_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13024-020-00368-6","article-title":"Initiation and propagation of alpha-synuclein aggregation in the nervous system","volume":"15","author":"Hijaz","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.taap.2021.115859_bb0135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tibs.2009.09.007","article-title":"Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown","volume":"35","author":"Houslay","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.taap.2021.115859_bb0140","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.redox.2016.12.008","article-title":"Parkin deficiency exacerbate ethanol-induced dopaminergic neurodegeneration by P38 pathway dependent inhibition of autophagy and mitochondrial function","volume":"11","author":"Hwang","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.taap.2021.115859_bb0145","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40035-020-00229-8","article-title":"Multitasking guardian of mitochondrial quality: Parkin function and Parkinson\u2019s disease","volume":"10","author":"Kamienieva","year":"2021","journal-title":"Translat. Neurodegen."},{"key":"10.1016\/j.taap.2021.115859_bb0150","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1042\/BJ20140334","article-title":"Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65","volume":"460","author":"Kazlauskaite","year":"2014","journal-title":"The Biochem. J."},{"key":"10.1016\/j.taap.2021.115859_bb0155","doi-asserted-by":"crossref","first-page":"21856","DOI":"10.1074\/jbc.M114.553297","article-title":"The H50Q mutation enhances alpha-synuclein aggregation, secretion, and toxicity","volume":"289","author":"Khalaf","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2021.115859_bb0160","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1021\/acschemneuro.6b00430","article-title":"Role of sporadic Parkinson disease associated mutations A18T and A29S in enhanced alpha-synuclein fibrillation and cytotoxicity","volume":"9","author":"Kumar","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.taap.2021.115859_bb0165","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1038\/s41467-018-04422-2","article-title":"Alpha-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson\u2019s disease","volume":"9","author":"Ludtmann","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.taap.2021.115859_bb0170","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s12035-016-0355-8","article-title":"Can cyclic nucleotide phosphodiesterase inhibitors be drugs for Parkinson\u2019s disease?","volume":"55","author":"Nthenge-Ngumbau","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.taap.2021.115859_bb0175","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","article-title":"Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease","volume":"109","author":"Rocha","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.taap.2021.115859_bb0180","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1007\/s00018-019-03386-w","article-title":"Molecular mechanism of olesoxime-mediated neuroprotection through targeting alpha-synuclein interaction with mitochondrial VDAC","volume":"77","author":"Rovini","year":"2020","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"10.1016\/j.taap.2021.115859_bb0185","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/jnc.12806","article-title":"Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of alpha-synuclein","volume":"131","author":"Rutherford","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.taap.2021.115859_bb0190","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/srep01002","article-title":"PINK1-mediated phosphorylation of the Parkin ubiquitin-like domain primes mitochondrial translocation of Parkin and regulates mitophagy","volume":"2","author":"Shiba-Fukushima","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2021.115859_bb0195","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCRESAHA.116.310179","article-title":"Beyond mitophagy: the diversity and complexity of Parkin function","volume":"120","author":"Shires","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.taap.2021.115859_bb0200","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s40265-019-01103-2","article-title":"Are all dopamine agonists essentially the same?","volume":"79","author":"Torti","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.taap.2021.115859_bb0205","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.acthis.2017.03.001","article-title":"A simple ImageJ macro tool for analyzing mitochondrial network morphology in mammalian cell culture","volume":"119","author":"Valente","year":"2017","journal-title":"Acta Histochem."},{"key":"10.1016\/j.taap.2021.115859_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101729","article-title":"A multi-faceted genotoxic network of alpha-synuclein in the nucleus and mitochondria of dopaminergic neurons in Parkinson\u2019s disease: emerging concepts and challenges","volume":"185","author":"Vasquez","year":"2020","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.taap.2021.115859_bb0215","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.7150\/ijbs.26230","article-title":"Targeting phosphodiesterase 4 as a potential therapeutic strategy for enhancing neuroplasticity following ischemic stroke","volume":"14","author":"Wang","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.taap.2021.115859_bb0220","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41401-020-0480-9","article-title":"Garciesculenxanthone B induces PINK1-Parkin-mediated mitophagy and prevents ischemia-reperfusion brain injury in mice","volume":"42","author":"Wu","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.taap.2021.115859_bb0225","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41401-019-0304-y","article-title":"Advances in the development of imaging probes and aggregation inhibitors for alpha-synuclein","volume":"41","author":"Xu","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.taap.2021.115859_bb0230","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.freeradbiomed.2020.12.018","article-title":"Roflumilast prevents ischemic stroke-induced neuronal damage by restricting GSK3beta-mediated oxidative stress and IRE1alpha\/TRAF2\/JNK pathway","volume":"163","author":"Xu","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2021.115859_bb0235","doi-asserted-by":"crossref","first-page":"25199","DOI":"10.1074\/jbc.M115.671446","article-title":"Site-specific interaction mapping of phosphorylated ubiquitin to uncover Parkin activation","volume":"290","author":"Yamano","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2021.115859_bb0240","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3390\/ijms19020513","article-title":"Inhibition of phosphodiesterase 4 by FCPR03 alleviates lipopolysaccharide-induced depressive-like behaviors in mice: involvement of p38 and JNK signaling pathways","volume":"19","author":"Yu","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2021.115859_bb0245","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.redox.2018.02.008","article-title":"Inhibition of phosphodiesterase 4 by FCPR16 protects SH-SY5Y cells against MPP(+)-induced decline of mitochondrial membrane potential and oxidative stress","volume":"16","author":"Zhong","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.taap.2021.115859_bb0250","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.freeradbiomed.2019.02.027","article-title":"Inhibition of PDE4 by FCPR16 induces AMPK-dependent autophagy and confers neuroprotection in SH-SY5Y cells and neurons exposed to MPP(+)-induced oxidative insult","volume":"135","author":"Zhong","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2021.115859_bb0255","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1111\/bph.14983","article-title":"Roflupram exerts neuroprotection via activation of CREB\/PGC-1alpha signalling in experimental models of Parkinson\u2019s disease","volume":"177","author":"Zhong","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2021.115859_bb0260","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1073\/pnas.0913485107","article-title":"Drosophila parkin requires PINK1 for mitochondrial translocation and ubiquitinates mitofusin","volume":"107","author":"Ziviani","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2021.115859_bb0265","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1124\/jpet.116.239608","article-title":"Novel phosphodiesterase 4 inhibitor FCPR03 alleviates lipopolysaccharide-induced neuroinflammation by regulation of the cAMP\/PKA\/CREB signaling pathway and NF-kappaB inhibition","volume":"362","author":"Zou","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X21004634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X21004634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:56:54Z","timestamp":1758574614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X21004634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":53,"alternative-id":["S0041008X21004634"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2021.115859","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Roflupram attenuates \u03b1-synuclein-induced cytotoxicity and promotes the mitochondrial translocation of Parkin in SH-SY5Y cells overexpressing A53T mutant \u03b1-synuclein","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2021.115859","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115859"}}